BrainsWay Ltd. (NASDAQ:BWAY) Short Interest Update

BrainsWay Ltd. (NASDAQ:BWAY) was the recipient of a significant increase in short interest during the month of July. As of July 15th, there was short interest totalling 39,300 shares, an increase of 8.3% from the June 30th total of 36,300 shares. Based on an average daily trading volume, of 59,900 shares, the days-to-cover ratio is currently 0.7 days.

BrainsWay Stock Performance

Shares of BWAY stock opened at $7.18 on Thursday. The business has a 50 day moving average of $6.39 and a two-hundred day moving average of $6.00. BrainsWay has a 52 week low of $2.25 and a 52 week high of $8.25.

BrainsWay (NASDAQ:BWAY) last released its quarterly earnings data on Wednesday, May 8th. The company reported $0.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.02. BrainsWay had a negative return on equity of 3.98% and a negative net margin of 4.83%. The business had revenue of $9.10 million during the quarter, compared to analyst estimates of $8.65 million. On average, research analysts forecast that BrainsWay will post 0.02 EPS for the current year.

Analysts Set New Price Targets

BWAY has been the topic of several research reports. HC Wainwright reissued a “buy” rating and set a $15.00 price target on shares of BrainsWay in a research report on Wednesday, June 5th. Oppenheimer boosted their target price on shares of BrainsWay from $10.00 to $11.00 and gave the company an “outperform” rating in a research note on Thursday, May 9th.

Hedge Funds Weigh In On BrainsWay

Several institutional investors have recently modified their holdings of the company. Jump Financial LLC bought a new position in shares of BrainsWay in the fourth quarter worth $207,000. Acadian Asset Management LLC lifted its holdings in BrainsWay by 583.2% in the 1st quarter. Acadian Asset Management LLC now owns 175,416 shares of the company’s stock valued at $923,000 after acquiring an additional 149,740 shares during the last quarter. Quadrature Capital Ltd bought a new position in shares of BrainsWay during the 4th quarter valued at about $70,000. Essex Investment Management Co. LLC acquired a new position in shares of BrainsWay in the 4th quarter worth approximately $1,531,000. Finally, Tucker Asset Management LLC grew its stake in shares of BrainsWay by 1,686.9% in the 4th quarter. Tucker Asset Management LLC now owns 5,450 shares of the company’s stock worth $35,000 after purchasing an additional 5,145 shares during the last quarter. Institutional investors own 30.11% of the company’s stock.

BrainsWay Company Profile

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases.